Stem Cells

Human stem cell combination could help damaged hearts live longer

6 August 2019 | By Rachael Harper (Drug Target Review)

A combination of heart cells derived from human stem cells could lead to developing a treatment for heart failure.

Targeting a blood stem cell subset shows lasting gene editing

31 July 2019 | By Drug Target Review

Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.

Whitepaper: Neural Cell Culturing Guide

22 July 2019 | By Bio-Techne

The advent of in vitro culturing of neural cells has been central to driving our understanding of the nervous system.

Leukemia stem cells made visible to the immune system

19 July 2019 | By Drug Target Review

A new study may provide the basis for combating malignant leukemia stem cells.

Study shows p38 protein regulates formation of new blood vessels

18 July 2019 | By Drug Target Review

A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.

Titian Software Ltd

Stem cell stimulation shown to improve stroke recovery

2 July 2019 | By Drug Target Review

Stem cell stimulation shows promise as a potential noninvasive stroke treatment.

Light-stimulated brain cells could aid in stroke recovery research

1 July 2019 | By Drug Target Review

A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.

Video: Ethical and regulatory use of biospecimens in the EU

1 July 2019 | By BioIVT

Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.

Statement issued by FDA on stem cell clinic’s permanent injunction

28 June 2019 | By Drug Target Review

The FDA has released a statement on US Stem Cell Clinic LLC and US Stem Cell Inc's permanent injunction.

Antibody treatment allows mismatched stem cell transplant in mice

18 June 2019 | By Drug Target Review

New study finds a combination of antibodies that can prepare mice to accept stem cells from an immunologically mismatched donor.

Stem-cell technologies in immunotherapy

17 June 2019 | By Aparajita Dubey (Associate Scientific Manager at Biocon Biologics Limited)

This article outlines the exciting developments that are taking place with immunotherapies and demonstrates how stem-cell technologies are proliferating the paradigm shift in how we tackle cancer treatment.

Using stem cells to study the effects of cannabis on neuronal development

17 June 2019 | By Thomas M. Durcan (McGill University), Trisha Rao (Montreal Neurological Institute)

Thanks to new developments with induced pluripotent stem cells enabling generation of human neurons, scientists can more precisely analyse the effects that chemicals have on human cells. This article describes research into the effects of cannabis on neuronal development and implications of its legalisation in Canada.

First blood-brain barrier chip using stem cells developed

13 June 2019 | By Drug Target Review

Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.

Research helps to show how neural stem cells are activated

10 June 2019 | By Drug Target Review

A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.